Results 31 to 40 of about 5,211,261 (208)

Allergic diseases in the elderly

open access: yesTranslational Medicine @ UniSa
Recent increases in allergic diseases are thought to be caused by better hygiene, Westernized diets, air pollution, climate change, and other factors that influence host microbiota, a key player in the induction and maintenance of immunoregulatory circuits and tolerance.
Di Lorenzo, Gabriele   +3 more
openaire   +4 more sources

Tregs and allergic disease [PDF]

open access: yesJournal of Clinical Investigation, 2004
Allergic diseases such as asthma, rhinitis, and eczema are increasing in prevalence and affect up to 15% of populations in Westernized countries. The description of Tregs as T cells that prevent development of autoimmune disease led to considerable interest in whether these Tregs were also normally involved in prevention of sensitization to allergens ...
Douglas S, Robinson   +2 more
openaire   +2 more sources

Immune and allergic responses to Anisakis pegreffii, with focus on the roles of IL-4, IL-13 and the IL-4 receptor alpha [PDF]

open access: yes, 2007
Includes bibliographical references (p. 117-127).The fish-parasitizing nematode Anisakis pegreffii induces gastrointestinal disease and allergy when ingested by humans, and can cause occupational allergy in seafood processing workers.
Nieuwenhuizen, Natalie
core   +1 more source

Flare of eosinophilic granulomatosis with polyangiitis related to pregnancy: Case report and review of the literature

open access: yesRespiratory Medicine Case Reports, 2019
Eosinophilic granulomatosis with polyangiitis (EGPA) is characterized by excessive eosinophil accumulation in the peripheral blood and affected tissues with development of granulomatous vasculitic organ damage.
Osamu Matsuno, Seijiro Minamoto
doaj   +1 more source

Allergic Rhinitis and its Associated Co-Morbidities at Bugando Medical Centre in Northwestern Tanzania; A Prospective Review of 190 Cases. [PDF]

open access: yes, 2012
Allergic rhinitis is one of the commonest atopic diseases which contribute to significant morbidity world wide while its epidemiology in Tanzania remains sparse.
Rambau, Peter   +14 more
core   +2 more sources

Case Report: Sequential use of tezepelumab and mepolizumab for eosinophilic otitis media in EGPA: a steroid-sparing strategy

open access: yesFrontiers in Allergy
Even in eosinophilic granulomatosis with polyangiitis (EGPA), not all manifestations of eosinophilic inflammation respond equally to anti–interleukin-5 (IL-5) therapy.
Osamu Matsuno   +4 more
doaj   +1 more source

Prenatal Maternal Depression Related to Allergic Rhinoconjunctivitis in the first 5 Years of Life in Children of the EDEN Mother-Child Cohort Study

open access: yesAllergy & Rhinology, 2017
Backgroud Evidence about the relationship between prenatal maternal depression and the development of childhood asthma and allergies in early life is scarce. We aimed to examine this relationship by using data set of EDEN mother-child cohort study.
Cailiang Zhou Ph.D.   +9 more
doaj   +1 more source

Allergic rhinitis and its impact on asthma (ARIA): achievements in 10 years and future needs [PDF]

open access: yes, 2012
Allergic rhinitis (AR) and asthma represent global health problems for all age groups. Asthma and rhinitis frequently coexist in the same subjects.
Kaliner, M.A.   +999 more
core   +1 more source

Biomarker-guided IL-5 blockade achieves steroid-free MPO-ANCA seroconversion in EGPA

open access: yesJournal of Allergy and Clinical Immunology: Global
This report describes a case of biopsy-confirmed EGPA in which early initiation of mepolizumab, guided by biomarker surveillance, resulted in steroid-free MPO-ANCA seroconversion.
Osamu Matsuno, MD, PhD   +3 more
doaj   +1 more source

Eosinophils depletion therapy for severe asthma management following favorable response to mepolizumab

open access: yesRespiratory Medicine Case Reports, 2019
We described three severe asthmatics whose asthma symptoms were rapidly improved by benralizumab following favorable response to mepolizumab. Benralizumab-induced eosinophil depletion contributed to clinical improvement of severe asthma after mepolizumab-
Osamu Matsuno, Seijiro Minamoto
doaj   +1 more source

Home - About - Disclaimer - Privacy